Zai Lab Ltd Ordinary Shares ZAILF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- $2.07 / $3.07
- Shares Outstanding
- 1.12B
- Market Cap
- —
- Volume/Avg
- 3M / 3M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,784
- Website
- https://www.zailaboratory.com
Valuation
|
Metric
|
ZAILF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ZAILF
|
|---|---|
Quick Ratio | 1.61 |
Current Ratio | 2.13 |
Interest Coverage | −35.53 |
Quick Ratio
ZAILF
Profitability
|
Metric
|
ZAILF
|
|---|---|
Return on Assets (Normalized) | −13.93% |
Return on Equity (Normalized) | −22.33% |
Return on Invested Capital (Normalized) | −19.27% |
Return on Assets
ZAILF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|gjV!X^m | LOCK|!>!vS | $131B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|s#@v@hL | LOCK|s>jk | $83B | |||
| argenx SE ADR
ARGX
| LOCK|<<?m^lZ | LOCK|&hG | $54B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|&xvDndp | LOCK|!>#R | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|pCpRk@ | LOCK|@CD | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|g#C?$Wh | LOCK|HSt<Q | $30B | |||
| Moderna Inc
MRNA
| LOCK|kD$F$x | LOCK|MLs | $25B | |||
| Incyte Corp
INCY
| LOCK|yjDXBpq | LOCK|m<& | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|<^rPjk | LOCK|&Kf | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|N<t?L> | LOCK|#>q | $16B |
United States